The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
205
Topical gel 1%-4 times daily
Topical gel-4 times daily
NCH investigative site
Bad Nauheim, Germany
NCH investigative site
Brühl, Germany
NCH investigative site
Cologne, Germany
NCH investigative site
Essen, Germany
Pain on Movement
Pain on Movement at 72 hours assessed on a 100 mm visual analog scale with anchors at 0="No pain" and 100= "Extreme pain"
Time frame: 72 hours
Onset of Pain Relief
Onset of perceptible pain relief.
Time frame: On day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
NCH investigative site
Gilching, Germany
NCH investigative site, Munich, Germany.
Munich, Germany